Concepedia

Keizo Sugasawa

KS

Statistics

Publications

11

Citations

429

H-Index

11

Active since

1996

Affiliations

Astellas Pharma (Japan)(Current)

Kyoto University

University of Pennsylvania

Nihon University

The University of Tokyo

Keizo Sugasawa is an author at Astellas Pharma (Japan) specializing in pharmacology, medicinal chemistry, and medicine.

Publications per year

1996–2013

11

Publications

11

AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonist

Mari Fukushima‐Shintani, Kenichi Suzuki, Yoshiyuki Iwatsuki et al. · European Journal Of Haematology · 2008 · 80 citations

, , +11

Solution structures of a monodentate chiral lithium amide in the presence of lithium halide

Keizo Sugasawa, Mitsuru Shindo, Hiroshi Noguchi et al. · Tetrahedron Letters · 1996 · 68 citations

, , +8

AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis

Mari Fukushima‐Shintani, Kenichi Suzuki, Yoshiyuki Iwatsuki et al. · Experimental Hematology · 2008 · 62 citations

, , +10

Direct Modulation of Microtubule Stability Contributes to Anthracene General Anesthesia

Daniel J. Emerson, Brian P. Weiser, John Psonis et al. · Journal of the American Chemical Society · 2013 · 59 citations

, , +14

Discovery of <i>N</i> -[2-Hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (Darexaban, YM150) as a Potent and Orally Available Factor Xa Inhibitor

Fukushi Hirayama, Hiroyuki Koshio, Tsukasa Ishihara et al. · Journal of Medicinal Chemistry · 2011 · 35 citations · Full text

, , +17

1–5 of 11